Inventor · disambiguated record
Oliver Planz
Also filed as: PLANZ OLIVER
4 granted patents·13 pending applications·10 citations·filing 2002–2024
68Inventor score
Files withATRIVA THERAPEUTICS GMBH9ACTIVAERO GMBH1INAMED GMBH INST FUER AEROSOLM1LUDWIG STEFAN1LUDWIG STEPHAN1
Top patents by PatentIndex Score
17 records- 0176US11903917B2MEK-inhibitor for the treatment of viral and bacterial infectionsATRIVA THERAPEUTICS GMBH·Filed 2018·Granted Feb 20, 2024·2 cites·18 claims
- 0276US9566281B2MEK inhibitors in the treatment of virus diseasesWESTFAELISCHE WILHELMS-UNIVERSITAET·Filed 2013·Granted Feb 14, 2017·7 cites·5 claims
- 0367US2024245637A1Mek-inhibitor for the treatment of viral and bacterial infectionsATRIVA THERAPEUTICS GMBH·Filed 2024·Application pending·0 cites
- 0464US8313751B2Compositions and methods for the prophylaxis or treatment of viral diseasesPLANZ OLIVER·Filed 2008·Granted Nov 20, 2012·1 cites·5 claims
- 0554US2009155270A1Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenzaACTIVAERO GMBH·Filed 2008·Application pending·0 cites
- 0653US12350244B2MEK-inhibitor for the treatment of viral and bacterial infectionsATRIVA THERAPEUTICS GMBH·Filed 2020·Granted Jul 8, 2025·0 cites·23 claims
- 0751US2023241014A1Mek-inhibitors for the treatment or prevention of coronavirus infections and/or covid-19 cytokine stormATRIVA THERAPEUTICS GMBH·Filed 2021·Application pending·0 cites
- 0850US2022152080A1Rsk inhibitors in the treatment of virus diseasesATRIVA THERAPEUTICS GMBH·Filed 2020·Application pending·0 cites
- 0950US2010239563A1Pharmaceutical composition for the prophylaxis and/or treatment of viral diseasesLUDWIG STEPHAN·Filed 2008·Application pending·0 cites
- 1050US2005129694A1Pharmaceutical composition for the prophylaxis and/or treatment of virus diseasesFiled 2002·Application pending·0 cites
- 1149US2017209450A1Mek inhibitors in the treatment of virus diseasesATRIVA THERAPEUTICS GMBH·Filed 2017·Application pending·0 cites
- 1247US2009074716A1method for treating influenza virus infectionVIROLOGIK GMBH·Filed 2008·Application pending·0 cites
- 1346US2022378730A1Mek inhibitors for the treatment of hantavirus infectionsATRIVA THERAPEUTICS GMBH·Filed 2020·Application pending·0 cites
- 1446US2022370384A1Combinations of mek inhibitors with cap-dependent endonuclease inhibitorsATRIVA THERAPEUTICS GMBH·Filed 2020·Application pending·0 cites
- 1546US2006247161A1Use of active ingredients for the prophylaxis and/or therapy of viral diseasesINAMED GMBH INST FUER AEROSOLM·Filed 2004·Application pending·0 cites
- 1645US2019298669A1Ci-1040 for the treatment of viral diseasesATRIVA THERAPEUTICS GMBH·Filed 2019·Application pending·0 cites
- 1744US2007172489A1Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenzaLUDWIG STEFAN·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →